Phoenix Blend

Phoenix Blend is a dual-mechanism growth-hormone-axis research formula that combines two complementary peptides in a single vial. Tesamorelin, a GRF(1-44)-NH2 analog, and Ipamorelin, a selective GHS-R1a agonist, act on different points of the GH axis — pairing a GHRH-analog mechanism with a selective secretagogue mechanism so researchers can study the two together rather than sourcing and combining them separately.

In research models, Tesamorelin is examined for its role in stimulating endogenous GH secretion and in visceral adipose reduction pathways, while Ipamorelin is studied for clean GH pulse stimulation without the cortisol or prolactin interference seen with some other secretagogues. Investigators use the pairing to explore how a GHRH-analog and a selective GHS-R1a agonist behave in combination within in-vitro systems. All material is intended strictly for in-vitro laboratory research.

The blend is offered in two ratio configurations — Tesamorelin 10mg with Ipamorelin 5mg, and Tesamorelin 12mg with Ipamorelin 2mg — so a study can select the compound ratio that matches its design instead of reconstituting two vials to approximate it. Both configurations are lyophilized and third-party lab tested at ≥98% purity by HPLC, with a Certificate of Analysis available on request. Store vials cool, dry, and away from direct light; refrigerate for longer-term storage and avoid repeated temperature swings.